Lv4
720 积分 2023-09-07 加入
Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC
5天前
已完结
Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion
5天前
已完结
Management of Brain Metastases in Non–Small-Cell Lung Cancer
30天前
已完结
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study
1个月前
已完结
Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor
2个月前
已完结
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
2个月前
已完结
Development of T follicular helper cells and their role in disease and immune system
2个月前
已完结
Differential Effects of JAK1 vs. JAK2 Inhibition in Mouse Models of Hemophagocytic Lymphohistiocytosis
3个月前
已完结
Immune Thrombocytopenia
3个月前
已完结
The peripheral T-cell lymphomas: an unusual path to cure
3个月前
已完结
皖公网安备34019202002308
